CAH:NYE-Cardinal Health Inc.

EQUITY | Medical Distribution | New York Stock Exchange

Last Closing

USD 49.05

Change

+0.88 (+1.83)%

Market Cap

USD 22.38B

Volume

2.72M

Analyst Target

USD 55.79
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Cardinal Health Inc is a healthcare services company. It provides healthcare services and products for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. Its segments are pharmaceutical and medical.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-01-18 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
MCK McKesson Corporation

+4.52 (+0.84%)

USD 70.80B
COR Cencora Inc.

+1.81 (+0.76%)

USD 38.52B
OMI Owens & Minor Inc

-0.62 (-2.51%)

USD 2.06B
NVG Nuveen AMT Free Municipal Cred..

-0.06 (-0.52%)

USD 3.29M

ETFs Containing CAH

FHH:CA First Trust AlphaDEX US H.. 2.10 % 0.77 %

-1.65 (-0.88%)

CAD 0.01B
FHH-F:CA First Trust AlphaDEX U.S... 2.10 % 0.00 %

+0.41 (+-0.88%)

CAD 0.01B
IQSA:LSE Invesco Quantitative Stra.. 1.68 % 0.00 %

-0.62 (-0.88%)

USD 0.24B
DEF 0.00 % 0.59 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

-0.09 (-0.88%)

USD 5.46M
FXH First Trust Health Care A.. 0.00 % 0.63 %

-1.30 (-0.88%)

USD 1.33B
IBDD 0.00 % 0.10 %

N/A

N/A
ONEO SPDR® Russell 1000 Momen.. 0.00 % 0.20 %

-0.23 (-0.88%)

USD 0.14B
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

-0.59 (-0.88%)

USD 0.62B
ONEY SPDR® Russell 1000® Yie.. 0.00 % 0.20 %

-0.57 (-0.88%)

USD 0.78B
PWC 0.00 % 0.59 %

N/A

N/A
QSY 0.00 % 0.38 %

N/A

N/A
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

-0.37 (-0.88%)

USD 0.02B
IVFVC 0.00 % 0.00 %

N/A

N/A
VALQ American Century STOXX U... 0.00 % 0.29 %

-0.41 (-0.88%)

USD 0.24B
UTRN Vesper U.S. Large Cap Sho.. 0.00 % 0.00 %

-0.10 (-0.88%)

USD 0.02B
DBLV 0.00 % 0.87 %

N/A

N/A
GBDV 0.00 % 0.00 %

N/A

N/A
IQSA:XETRA Invesco Quantitative Stra.. 0.00 % 0.00 %

-0.79 (-0.88%)

USD 0.07B
IQSE:XETRA Invesco Quantitative Stra.. 0.00 % 0.00 %

-0.63 (-0.88%)

USD 0.05B

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.98% 60% D- 70% C-
Dividend Return N/A N/A N/A N/A F
Total Return 9.98% 60% D- 70% C-
Trailing 12 Months  
Capital Gain -31.60% 60% D- 12% F
Dividend Return 2.64% 75% C 49% F
Total Return -28.96% 60% D- 12% F
Trailing 5 Years  
Capital Gain -27.53% 40% F 24% F
Dividend Return 12.26% 75% C 42% F
Total Return -15.27% 60% D- 22% F
Average Annual (5 Year Horizon)  
Capital Gain -5.18% 60% D- 17% F
Dividend Return -2.99% 60% D- 15% F
Total Return 2.19% 75% C 44% F
Risk Return Profile  
Volatility (Standard Deviation) 16.43% 100% F 45% F
Risk Adjusted Return -18.22% 60% D- 17% F
Market Capitalization 22.38B 60% D- 89% A-

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Distribution) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 17.00 40% 30%
Price/Book Ratio 2.43 60% 31%
Price / Cash Flow Ratio 1.96 40% 58%
Price/Free Cash Flow Ratio 9.60 40% 54%
Management Effectiveness  
Return on Equity 10.85% 60% 59%
Return on Invested Capital 11.82% 60% 62%
Return on Assets 1.79% 60% 43%
Debt to Equity Ratio 139.00% 80% 26%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector